Literature DB >> 27974056

A pilot study using "apps" as a novel strategy for the management of challenging behaviors seen in people living in residential care.

Samantha M Loi1, Angela Mazur2, David Huppert2, Bernadette Hoy2, Jodie Swan2, Nicola T Lautenschlager1.   

Abstract

BACKGROUND: Many adults living in residential care will demonstrate challenging behaviors. Non-pharmacological strategies are recommended as first-line treatment. Using applications (apps) is a novel approach to managing these behaviors, and has yet to be assessed in this group. This paper describes a pilot study to test apps as a novel non-pharmacological strategy to manage challenging behaviors in adults living in residential care.
METHODS: A non-blinded, non-randomized crossover trial design was implemented which compared apps to a control situation and usual care to determine whether apps were able to decrease challenging behaviors. The primary outcome measure was the Neuropsychiatric Inventory (NPI) that measures the frequency and severity of these behaviors.
RESULTS: Fifteen residents participated whose mean age was 78.5 years. There were a range of diagnoses and comorbidities, including dementia and schizophrenia. IPads were used as the medium for delivering the apps and residential care staff implemented the interventions. There was a significant decrease in the total NPI score using the apps intervention (10.6 points) compared to the control (17.7 points) and to usual care (21.1 points). There was positive qualitative feedback from the staff who were involved in the study, but they also cited barriers such as lack of confidence using the apps and lack of time.
CONCLUSIONS: Although this was a small and limited study, results suggest that using apps may be a feasible and personalized approach to managing challenging behaviors. A more rigorous study design that includes larger sample sizes and staff training may enable further research and benefits in this area.

Entities:  

Keywords:  challenging behaviors; non-pharmacological; residential facilities; touchscreen technology

Mesh:

Year:  2016        PMID: 27974056     DOI: 10.1017/S1041610216002039

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  6 in total

Review 1.  Use of touchscreen tablet technology by people with dementia in homes: A scoping review.

Authors:  Danielle Hitch; Jodie Swan; Ruth Pattison; Rachel Stefaniak
Journal:  J Rehabil Assist Technol Eng       Date:  2017-10-31

2.  Use of touch screen tablets to support social connections and reduce responsive behaviours among people with dementia in care settings: a scoping review protocol.

Authors:  Lillian Hung; Annette Berndt; Christine Wallsworth; Neil Horne; Mario Gregorio; Jim Mann; Cathy Son; Ainsley Camps; Bryan Chow; Ryan O'Neill; Habib Chaudhury
Journal:  BMJ Open       Date:  2019-11-19       Impact factor: 2.692

3.  Creating a toolkit with stakeholders for leveraging tablet computers to support person-centred dementia care in hospitals.

Authors:  John Shadarevian; Cheryl Chan; Annette Berndt; Cathy Son; Mario Gregorio; Neil Horne; Jim Mann; Christine Wallsworth; Bryan Chow; Ryan O'Neill; Lillian Hung
Journal:  J Rehabil Assist Technol Eng       Date:  2020-11-23

Review 4.  Ambient assisted living technology-mediated interventions for older people and their informal carers in the context of healthy ageing: A scoping review.

Authors:  Maria Y Nilsson; Stefan Andersson; Lennart Magnusson; Elizabeth Hanson
Journal:  Health Sci Rep       Date:  2020-12-28

5.  Digital technologies to support people living with dementia in the care home setting to engage in meaningful occupations: protocol for a scoping review.

Authors:  Nicholas Luscombe; Sarah Morgan-Trimmer; Sharon Savage; Louise Allan
Journal:  Syst Rev       Date:  2021-06-21

Review 6.  De-escalation techniques for managing non-psychosis induced aggression in adults.

Authors:  Sally Spencer; Paula Johnson; Ian C Smith
Journal:  Cochrane Database Syst Rev       Date:  2018-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.